Dr. Öğr. Üyesi İrem Peker Eyüboğlu

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
Breast NeoplasmsBrain Injuries, Traumatic
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Brain Injuries, Traumatic 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceTıbbi Biyolojisaglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 7 publications · Model version —From source
  • Publications45 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0003-0764-9841ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393619/doktorlarimiz.html#irem-peker-eyuboglusaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

45 publications

  1. Neurobehavioral and physiological changes in pregnant rats following REM sleep deprivation model

    Marmara medical journal, 2026

    DOI 10.5472/marumj.1873511 Open-access full textSource: OpenAlex

  2. NOS1AP: a potential subtype-specific dual role as a tumor suppressor and oncogene in breast cancer subtypes

    Molecular Biology Reports, 2026

    DOI 10.1007/s11033-025-11178-8 PMID 41128806 1 citation (Europe PMC) Source: ORCID

  3. Targeting Mitochondrial and Inflammatory Pathways in Abdominal Aortic Aneurysm: Discovery of Sigma-1 and PPAR-γ Agonists through Plasma MicroRNA Profiling

    Turkish Journal of Biology, 2026

    DOI 10.55730/1300-0152.2983 Open-access full textSource: ORCID

  4. Fisetin Modulates Chemoresistance-Associated miR-21, miR-181a, miR-203, miR-101 and miR-381 in Capecitabine-Resistant HT29 Colorectal Cancer Cells

    Biochemical Genetics, 2026

    DOI 10.1007/s10528-026-11412-3 PMID 42277456 Source: ORCID

  5. Association of certain biochemical parameters related to bone cycle with genotype in MPS IIIB patients

    Turkish journal of medical sciences, 2025

    DOI 10.55730/1300-0144.5973 PMID 40104299 Open-access full textSource: Europe PMC

  6. Elabela alleviates ischemia/reperfusion-induced hepatic and remote organ injury by inhibiting oxidative stress in rats

    Pflügers Archiv - European Journal of Physiology, 2025

    DOI 10.1007/s00424-025-03105-4 PMID 40679610 1 citation (OpenAlex) Source: OpenAlex

  7. Therapeutic efficacy of tofacitinib in PDSAg-induced chronic experimental autoimmune uveitis in Wistar rat

    Immunopharmacology and Immunotoxicology, 2025

    DOI 10.1080/08923973.2025.2508278 PMID 40433864 Source: OpenAlex

  8. Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria

    Archives of Dermatological Research, 2024

    DOI 10.1007/s00403-024-02966-6 PMID 38795119 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

    International Journal of Breast Cancer, 2024

    DOI 10.1155/2024/6117394 PMID 39574517 2 citations (Europe PMC) Open-access full textSource: ORCID

  10. Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelialmesenchymal transition in breast cancer patients undergoing NACT

    Turkish Journal of Medical Sciences, 2024

    DOI 10.55730/1300-0144.5834 PMID 39295614 4 citations (Europe PMC) Open-access full textSource: ORCID

View all 45 publications